Come contattare il centro
Centro HCP
Fornire un'alta qualità verificabile
Offrire assistenza sanitaria partecipativa e personalizzata
Utilizzando le nostre risorse in modo efficiente
Partecipare a reti sostenibili e professionali in ogni ambito
Il dipartimento di oftalmologia del Radboudumc è un centro terziario di alto livello per varie malattie degli occhi ed è uno dei massimi esperti nel trattamento e nella gestione delle malattie della retina. Oltre all'assistenza clinica quotidiana, effettuiamo ricerche sulle malattie della retina. Gli obiettivi principali della nostra ricerca sono comprendere meglio le basi molecolari di queste malattie e sviluppare nuovi dispositivi diagnostici e terapie.
Il dipartimento di genetica umana del Radboudumc svolge ricerche pionieristiche sulla relazione tra geni e malattie. La cura dei pazienti (divisione di genetica clinica) e la diagnostica genetica (divisione di diagnostica del genoma) eseguite all'interno del dipartimento di genetica umana sono ospitate da un centro ufficiale e acclamato di genetica clinica.
Immagine: .Koen
Contatti
Radboud university medical center, Nijmegen, Netherlands
Team
Pr Carel HOYNG
Olanda
Pr Frans Cremers
Olanda
Test clinici
NAC Attack, A Phase III, Multicenter, Randomized, Parallel, Double Masked, Placebo-Controlled Study Evaluating the Efficacy and Safety of Oral N-Acetylcysteine in Patients With Retinitis Pigmentosa
A Double-Masked, Randomized, Controlled, Multiple-Dose Study to Evaluate the Efficacy, Safety and Tolerability of Ultevursen in Subjects With Retinitis Pigmentosa (RP) Due to Mutations in Exon 13 of the USH2A Gene (Sirius)
A Collaborative Resource of Heidelberg Multimodal Imaging of Intermediate and Early Atrophic AMD Cases to Study Prediction of Disease Progression: (INTERCEPT-AMD)
Steroid Eye Drops Versus Placebo Eye Drops in Chronic Central Serous Chorioretinopathy Trial (PICS Trial)
Phase 3 Randomized, Controlled Study of AAV5-hRKp.RPGR for the Treatment of X-linked Retinitis Pigmentosa Associated With Variants in the RPGR Gene
Phase 3 Follow-up Study of AAV5-hRKp.RPGR for the Treatment of X-linked Retinitis Pigmentosa Associated With Variants in the RPGR Gene
Rate of Progression in EYS Related Retinal Degeneration (Pro-EYS).
A double-masked, randomized, controlled, multiple-dose study to evaluate the efficacy, safety, tolerability and systemic exposure of QR-110 in Subjects with Leber’s Congenital Amaurosis (LCA) due to c.2991+1655A>G mutation (p.Cys998X) in the CEP290 gene (Illuminate).
Safety and Efficacy of Emixustat in Stargardt Disease.
Natural History of the Progression of Choroideremia Study NSR-CHM-OS1.
Rate of Progression in USH2A Related Retinal Degeneration
A Long-term Follow-up Study to Evaluate the Safety and efficacy of Retinal Gene Therapy in Subjects with choroideremia treated previously with Adeno-Associated Viral Vector Encoding Rab Escort Protein-1 (AAV2-REP1) in an Antecedent Study.
Half-dose photodynamic therapy versus eplerenone treatment in chronic centralserous chorioretinopathy.
A Non-interventional Study of Clinical Experience in Patients Prescribed Raxone® for the Treatment of Leber’s Hereditary Optic Neuropathy (LHON).
A Phase 3, Open-Label, Multicenter, Extension Study to Evaluate the Long-Term Safety and Efficacy of Pegcetacoplan in Subjects With Geographic Atrophy Secondary to Age-Related Macular Degeneration
Rate of Progression of PCDH15-Related Retinal Degeneration in Usher
Natural history of the progression of X-linked retinitis pigmentosa.